awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37679893-37365A29-BBE0-4D8C-915E-ED6C13959F23
Q37679893-37365A29-BBE0-4D8C-915E-ED6C13959F23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37679893-37365A29-BBE0-4D8C-915E-ED6C13959F23
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
P2860
Q37679893-37365A29-BBE0-4D8C-915E-ED6C13959F23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37679893-37365A29-BBE0-4D8C-915E-ED6C13959F23
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d171b5d4dcee5f85a126f2e9bf2bc1b0500126de
P2860
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.